{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:02:29Z","timestamp":1789617749825,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","award":["2004958561"],"award-info":[{"award-number":["2004958561"]}],"id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019743","name":"West Virginia Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["5U54GM104942-05"],"award-info":[{"award-number":["5U54GM104942-05"]}],"id":[{"id":"10.13039\/100019743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jneuroim.2022.577939","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T20:49:40Z","timestamp":1659386980000},"page":"577939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review"],"prefix":"10.1016","volume":"371","author":[{"given":"Parissa","family":"Feizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya R.","family":"Pasham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Nirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitiz","family":"Sriwastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/neurolint13010010","article-title":"Acute and post-acute neurological complications of COVID-19","volume":"13","author":"Al-Ramadan","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0010","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.inat.2021.101320","article-title":"Optic neuritis post-COVID-19 infection. A case report with meta-analysis","volume":"26","author":"Azab","year":"2021","journal-title":"Interdiscip. Neurosurg."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0015","doi-asserted-by":"crossref","first-page":"119862","DOI":"10.1016\/j.jns.2021.119862","article-title":"A case of neuromyelitis optica spectrum disorder (NMOSD) and acute myositis following SARS-CoV-2 infection","volume":"429","author":"Barone","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0025","first-page":"1","article-title":"Covid-19 infection-induced neuromyelitis optica: a case report","volume":"30","author":"Batum","year":"2020","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2007.02.002","article-title":"Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients","volume":"123","author":"Boucher","year":"2007","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase in the CNS of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577939_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"21","key":"10.1016\/j.jneuroim.2022.577939_bb0045","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577939_bb0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1352458520949988","article-title":"J\u00fanior, Hygino da Cruz LC J\u00fanior. COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: cause or coincidence?","volume":"27","author":"Corr\u00eaa","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0055","first-page":"109239","article-title":"A mechanism of virus-induced demyelination","volume":"2010","author":"Das","year":"2010","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0065","series-title":"An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","author":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia","year":"2022"},{"issue":"11","key":"10.1016\/j.jneuroim.2022.577939_bb0070","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s00415-020-09996-w","article-title":"First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease","volume":"267","author":"Domingues","year":"2020","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577939_bb0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ana.26041","article-title":"Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019","volume":"89","author":"Esp\u00edndola","year":"2021","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577939_bb0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0085","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0090","doi-asserted-by":"crossref","first-page":"577439","DOI":"10.1016\/j.jneuroim.2020.577439","article-title":"A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection","volume":"350","author":"Ghosh","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577939_bb0100","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577939_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1352458516663853","article-title":"The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates","volume":"23","author":"Hamid","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0110","series-title":"Harrison\u2019s Principles of Internal Medicine","article-title":"Multiple sclerosis and other demyelinating diseases","volume":"vol. 19e","author":"Hauser","year":"2014"},{"issue":"19","key":"10.1016\/j.jneuroim.2022.577939_bb0115","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.0000000000002655","article-title":"Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder","volume":"86","author":"Hyun","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0120","doi-asserted-by":"crossref","first-page":"577765","DOI":"10.1016\/j.jneuroim.2021.577765","article-title":"A systematic review of cases of CNS demyelination following COVID-19 vaccination","volume":"362","author":"Ismail","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","article-title":"The structure and function of myelin Oligodendrocyte glycoprotein","volume":"72","author":"Johns","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0130","series-title":"The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects: Workshop Summary","article-title":"Demyelinating diseases","author":"Johnson","year":"2004"},{"issue":"8","key":"10.1016\/j.jneuroim.2022.577939_bb0135","article-title":"Demyelinating disease of the central nervous system concurrent with COVID-19","volume":"13","author":"Karsidag","year":"2021","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577939_bb0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","article-title":"Neurological complications during treatment of Middle East respiratory syndrome","volume":"13","author":"Kim","year":"2017","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"issue":"19","key":"10.1016\/j.jneuroim.2022.577939_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025865","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: a case report","volume":"100","author":"Kogure","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577939_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cells9020482","article-title":"T helper cells: the modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577939_bb0165","article-title":"COVID-19 pandemic: a neurological perspective","volume":"12","author":"Lahiri","year":"2020","journal-title":"Cureus."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577939_bb0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0175","doi-asserted-by":"crossref","first-page":"117316","DOI":"10.1016\/j.jns.2021.117316","article-title":"Cerebrospinal fluid in COVID-19: A systematic review of the literature","volume":"421","author":"Lewis","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577939_bb0180","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jns.2015.09.374","article-title":"Neuromyelitis optica spectrum disorder and varicella-zoster infection","volume":"358","author":"Machado","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577939_bb0185","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2022.577939_bb0190","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577939_bb0195","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1007\/s12035-020-02094-y","article-title":"Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms","volume":"57","author":"Mohammadi","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0200","doi-asserted-by":"crossref","first-page":"100299","DOI":"10.1016\/j.ensci.2020.100299","article-title":"A first presentation of multiple sclerosis with concurrent COVID-19 infection","volume":"22","author":"Moore","year":"2021","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jneuroim.2022.577939_bb0205","doi-asserted-by":"crossref","first-page":"577523","DOI":"10.1016\/j.jneuroim.2021.577523","article-title":"Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: a case report and review of literature","volume":"353","author":"Moreno-Escobar","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.msard.2017.07.023","article-title":"A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection","volume":"17","author":"Nakamura","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0215","doi-asserted-by":"crossref","first-page":"117090","DOI":"10.1016\/j.jns.2020.117090","article-title":"Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms","volume":"418","author":"Neumann","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41591-021-01647-5","article-title":"Post-acute neurological consequences of COVID-19: an unequal burden","volume":"28","author":"Nolen","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577939_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0230","doi-asserted-by":"crossref","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577939_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2013.07.2510","article-title":"A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster","volume":"334","author":"Park","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0240","doi-asserted-by":"crossref","first-page":"102857","DOI":"10.1016\/j.msard.2021.102857","article-title":"MOG-associated encephalitis following SARS-COV-2 infection","volume":"50","author":"Peters","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577939_bb0245","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000813","article-title":"CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19","volume":"7","author":"Pinto","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0250","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.1016\/j.msard.2020.102474","article-title":"Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: a case report","volume":"46","author":"de Ruijter","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577939_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4347","article-title":"The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID-19 infection","volume":"9","author":"Sardar","year":"2021","journal-title":"Clin. Case Rep."},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577939_bb0260","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/v13102091","article-title":"The potential role of COVID-19 in the pathogenesis of multiple sclerosis-a preliminary report","volume":"13","author":"Satheesh","year":"2021","journal-title":"Viruses."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577939_bb0265","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577939_bb0270","article-title":"COVID-19-induced acute bilateral optic neuritis","volume":"8","author":"Sawalha","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577939_bb0275","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00415-020-10131-y","article-title":"COVID-19: dealing with a potential risk factor for chronic neurological disorders","volume":"268","author":"Schirinzi","year":"2021","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577939_bb0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577939_bb0285","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s13760-021-01691-5","article-title":"Demyelination as a result of an immune response in patients with COVID-19","volume":"121","author":"Shabani","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0290","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-319-33189-8_6","article-title":"Virus-induced demyelination: the case for virus(es) in multiple sclerosis","author":"Soldan","year":"2016","journal-title":"Neurotrop. Viral Infect."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0295","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijid.2021.01.002","article-title":"A comprehensive systematic review of CSF analysis that defines neurological manifestations of COVID-19","volume":"104","author":"Tandon","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"10130","key":"10.1016\/j.jneuroim.2022.577939_bb0300","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577939_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0310","author":"WHO"},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577939_bb0315","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0320","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0325","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0330","first-page":"6682251","article-title":"Demyelinating changes alike to multiple sclerosis: a case report of rare manifestations of COVID-19","volume":"2020","author":"Yavari","year":"2020","journal-title":"Case Rep. Neurol. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577939_bb0335","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WNO.0000000000001049","article-title":"Myelin Oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0340","doi-asserted-by":"crossref","first-page":"102324","DOI":"10.1016\/j.msard.2020.102324","article-title":"A case of possible atypical demyelinating event of the central nervous system following COVID-19","volume":"44","author":"Zoghi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2022.577939_bb0345","first-page":"349","article-title":"Optic neuritis in a patient with seropositive myelin oligodendrocyte glycoprotein antibody during the post-COVID-19 period","volume":"14","author":"\u017dori\u0107","year":"2021","journal-title":"Int. Med. Case Rep. J."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:21Z","timestamp":1759048881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":69,"alternative-id":["S0165572822001345"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577939","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577939"}}